POET Technologies is still very early in its growth. Revenue grew 112% year over year with six straight quarters of sequential growth, and it is showcasing new laser light source technology for AI interconnects this week. It is one worth being patient with. x.com 

POET's deal with Lumilens is a $500M validation that could move it from lab tech to commercial scale. The supply and joint development agreement starts with a $50M order for optical engines and could scale to $500M over five years, with samples in late 2026 and volume production in 2027. Its optical interposer integrates electronics and photonics in one chip-scale package, beating power-hungry pluggables. 2026 should be the year of validation, 2027 the year of revenue. x.com 

POET Technologies' Lumilens deal looks weak because Lumilens lacks the cash to pay for its purchase orders and needs POET's stock to soar to cash out. Lumilens has nothing in an ultra-competitive optics sector with China. Claims of billions in orders are false; any Amazon order depends on executing several steps first, while Coherent sells about $5B of optics after 30+ years with access to fabs, lasers and ICs. x.com  x.com 

POET Technologies is the upstream pick-and-shovel for Celestial AI's Photonic Fabric, which Marvell just acquired for about $5B. POET supplies the light source that powers it, and Marvell has the hyperscaler relationships with AWS, Google and Meta to deploy it at scale. Revenue is still early, but once Marvell integrates Celestial and ramps production orders, the market should recognize POET's value; Q3 or Q4 2026 could be the inflection, and patience is required. x.com 

POET Technologies has several catalysts that could collapse its roughly 1,000x price-to-sales multiple and force an institutional rerating. Management targets over 30,000 Infinity optical engine shipments in 2026, the shift from lab demo to commercial revenue. It is co-developing 400G-1.6T modules with LITEON and Lessengers for AI data centers. Redomiciling to the US removes PFIC tax risk that suppressed US institutional ownership, while $430M of cash funds a Malaysia manufacturing ramp. x.com 

POET Technologies is uninvestable because its management has lost the trust of the big players. In April its CFO leaked information that led to the cancellation of Celestial AI and Marvell contracts. Being early in interposers and packaging does not make it a co-packaged optics winner, as others will catch up. Its TFLN partner QCI trails Hyperlight and is stuck on a 6-inch line, with no 8-inch wafer demo yet to show it can scale. x.com  x.com 

POET's new Lumilens order could make it a pivotal niche bottleneck in AI infrastructure, with a wide moat. Lumilens placed a $50M initial order for POET's AI photonic optical engines, with a potential $500M over five years. If it truly works, it could be colossal, a Vertiv-like story developing in real time. The CEO, a former GlobalFoundries vice president with foundry-level manufacturing experience, could make POET central to the photonics industry. x.com  x.com  x.com  x.com 

POET is derisked by confirmation that its customer Lumilens is a large, well-funded hyperscaler supplier. Lumilens emerged from stealth at a $5.5B valuation after raising $700M, with a multi-billion-dollar customer agreement, confirming earlier mapping that it supplies a top-three hyperscaler. POET has a $50M Lumilens purchase order, scalable to $500M, plus contracts with Sivers, on top of its large balance sheet. Lumilens's rise is also great for optical valuations generally. x.com 

POET has lost its anchor customer, and the way it happened signals a company that is a mess from the top down. Marvell canceled all its Celestial orders, including initial production units POET had touted since around 2023, after POET's CFO disclosed confidential information in an interview. Years of heavy dilution add to the damage. $430 million of cash plus a $400 million May raise covers years of burn at about $9 million a quarter, so dilution could ease, but with this management, who knows. … Show more

The market does not understand the potential of Sivers Semiconductors' collaboration with POET Technologies. Per @aleabitoreddit, POET's confirmation of "far in excess" of purchase orders, on top of its Marvell supplier relationships, translates materially to Sivers laser production, and markets have not fully priced in either. x.com